Precision System Science (7707) · FactAchieved
Transfer of All Shares in Universal Bio Research
First written in FY2024. 1 of 2 entries say "Achieved", first in FY2025-H1. Latest entry: FY2025-H1.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Removal from the Scope of Consolidation Through the Transfer of Shares in a SubsidiaryA theme 307 companies write about · 44 as a headwind · 217 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 156 companies compared. The sentences above are computed from all 156.Comparing 200 of the theme's 389 threads.Full recordFilings, disclosures and news, newest first
- FY2025-H1AchievedAnnual report
「Number of shares transferred: 1,200 shares” “Transfer price: ¥60 million” “Voting rights ownership ratio before transfer: 100%” “Voting rights ownership ratio after transfer: －%」
All 1,200 shares held in UBR were transferred for ¥60 million on 1 January 2025, reducing the voting rights ownership ratio from 100% to zero. - FY2024First statedAnnual report
「On 14 August 2024, we resolved to transfer all shares in UBR held by us, concerning our consolidated subsidiary ユニバーサル・バイオ・リサーチ株式会社, to Tajima Shuji (田島秀二), its representative director. Following this share transfer, UBR, currently a consolidated subsidiary, is scheduled to be excluded from our consolidated subsidiaries from the third quarter of the fiscal year ending June 2025.」
As part of a review of the business portfolio and efforts to strengthen the financial position, the company transferred all shares in its wholly owned subsidiary UBR, with the subsequent event that UBR is scheduled to be excluded from consolidation from the third quarter of the fiscal year ending June 2025.